Cardiometabolic traits at hospital admission impact on outcome in STEMI: insights from the prospective SYSTEMI Trial in completely revascularized patients

Abstract Outcomes after ST-elevation myocardial infarction (STEMI) differ between randomized controlled trials (RCTs) and real-world registries despite guideline-directed care. The cardiometabolic profiles of these populations remain incompletely illustrated. We aimed to characterize contemporary STEMI patients using detailed prospectively collected metabolic, renal, and inflammatory phenotyping data from the SYSTEMI study and to compare these with contemporary STEMI RCT and registry cohorts. Among 833 SYSTEMI patients (74% male; mean age 64 years), 24.5% presented with cardiogenic shock and 23.4% with out-of-hospital cardiac arrest (OHCA). Cardiovascular (CV) risk factors and CV disease (CVD) history included smoking (41%), arterial hypertension (60%), chronic kidney disease (CKD III-V 21%), prior myocardial infarction (11%), prior stroke (4%), peripheral arterial disease (8%). Dysglycemia was common (27% type 2 diabetes, 24% prediabetes) and was accompanied by higher C-reactive protein levels (CPR) in patients with type 2 diabetes. Among 25 RCTs (30,646 patients) and 43 registries (1,332,993 patients) from the complete-revascularization era, RCT cohorts were consistently younger, less comorbid, and reported lower in-hospital mortality than registries. SYSTEMI, characterizing cardiometabolic traits in contemporary STEMI patients, most closely resembled European and North American registries in demographics and CVD burden. Within SYSTEMI, CKD, admission CRP, and admission glucose were associated with in-hospital mortality after multivariable adjustment.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-74274-0
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiometabolic traits at hospital admission impact on outcome in STEMI: insights from the prospective SYSTEMI Trial in completely revascularized patients

Norbert Gerdes, Dragos Andrei Duse, Ralf Erkens, Carolin Helten et al.
1 links
Scientific Reports
Acute Myocardial Infarction Research
article

Cardiometabolic traits at hospital admission impact on outcome in STEMI: insights from the prospective SYSTEMI Trial in completely revascularized patients

Norbert Gerdes, Dragos Andrei Duse, Ralf Erkens, Carolin Helten, Stephan Angendohr, Christian Jung, Michael Roden, Amin Polzin, Maryna Masyuk, Madlen Kaldirim, Ann‐Kathrin Kahle, Jacqueline Georgy, Jean Marc Haurand, Oana‐Patricia Zaharia, Florian Bönner, Niklas Ophoff, Patricia Wischmann, Mareike Gastl, Kian Marjani, Christian Meyer, Karin Alde, Robert Wagner, Malte Kelm, Philipp Mourikis, Fabian Nienhaus
article en

Abstract

Abstract Outcomes after ST-elevation myocardial infarction (STEMI) differ between randomized controlled trials (RCTs) and real-world registries despite guideline-directed care. The cardiometabolic profiles of these populations remain incompletely illustrated. We aimed to characterize contemporary STEMI patients using detailed prospectively collected metabolic, renal, and inflammatory phenotyping data from the SYSTEMI study and to compare these with contemporary STEMI RCT and registry cohorts. Among 833 SYSTEMI patients (74% male; mean age 64 years), 24.5% presented with cardiogenic shock and 23.4% with out-of-hospital cardiac arrest (OHCA). Cardiovascular (CV) risk factors and CV disease (CVD) history included smoking (41%), arterial hypertension (60%), chronic kidney disease (CKD III-V 21%), prior myocardial infarction (11%), prior stroke (4%), peripheral arterial disease (8%). Dysglycemia was common (27% type 2 diabetes, 24% prediabetes) and was accompanied by higher C-reactive protein levels (CPR) in patients with type 2 diabetes. Among 25 RCTs (30,646 patients) and 43 registries (1,332,993 patients) from the complete-revascularization era, RCT cohorts were consistently younger, less comorbid, and reported lower in-hospital mortality than registries. SYSTEMI, characterizing cardiometabolic traits in contemporary STEMI patients, most closely resembled European and North American registries in demographics and CVD burden. Within SYSTEMI, CKD, admission CRP, and admission glucose were associated with in-hospital mortality after multivariable adjustment.

Scientific ReportsVol. 16(1)
Düsseldorf University Hospital (DE), Evangelisches Krankenhaus Düsseldorf (DE), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), Heinrich Heine University Düsseldorf (DE)
Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Luft- und Raumfahrt, Deutsche Herzstiftung, Bundesministerium für Wirtschaft und Energie
Good health and well-being
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon